Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Nanotechnology-Based Theranostic Approaches in Brain Diseases Publisher



Masoudifar R1 ; Moezzi SMI1 ; Shahrbabak SM1 ; Ahmadi M2, 3 ; Hajihosseini S1 ; Anvari Z4 ; Saadati S4 ; Pouyanfar N4 ; Ghorbanibidkorpeh F4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Pharmaceutics, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Medical Nanotechnology and Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  4. 4. Department of Pharmaceutics and Pharmaceutical Nanotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Source: Theranostics Nanomaterials in Drug Delivery Published:2024


Abstract

Brain disorders pose significant challenges owing to the blood-brain barrier (BBB), which presents a formidable obstacle to the delivery of therapeutic or diagnostic agents, impeding their access to specific target areas within the brain. Therefore, it is pivotal to constantly monitor the progress of brain diseases or the effectiveness of the treatment. However, constant imaging is tiresome and time-consuming for patients and physicians alike. Thus, the imaging agents should be co-delivered with the therapeutics to demonstrate a theranostic process that can be more efficient and straightforward in clinical application. Nanotechnology, which entails the science of submicron materials, is a means to hinder the issues accompanied by consuming conventional drugs, problems such as adverse drug reactions, or the drug reaching unwanted sites. The nano-sized carriers can engulf the theranostic agents and deliver more effectively. Using nanotechnology is also beneficial in setting up useful theranostic programs for patients. Theranostics can be applied in various brain diseases with the assistance of systems in the nano range to gain maximum benefit from both wings of a suitable treatment. Hence, within the confines of this book chapter, we aimed to expound upon the nano-based theranostic approaches employed in the context of neurological and brain disorders. © 2025 Elsevier Inc. All rights reserved.
Other Related Docs
9. A Concise Review on Cancer Treatment Methods and Delivery Systems, Journal of Drug Delivery Science and Technology (2019)
10. Circular Rnas in Glioblastoma, Clinica Chimica Acta (2025)
17. Lipidomics-Driven Drug Discovery and Delivery Strategies in Glioblastoma, Biochimica et Biophysica Acta - Molecular Basis of Disease (2025)
18. An Update on Actively Targeted Liposomes in Advanced Drug Delivery to Glioma, International Journal of Pharmaceutics (2021)